View in EDS PDF Full Text

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.

Saved in:
Bibliographic Details
Title: Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Authors: Rosenblum, Hannah G.1,2 hrosenblum@cdc.gov, Hadler, Stephen C.1, Moulia, Danielle1, Shimabukuro, Tom T.1, Su, John R.1, Tepper, Naomi K.1, Ess, Kevin C.1, Woo, Emily Jane3, Mba-Jonas, Adamma3, Alimchandani, Meghna3, Nair, Narayan3, Klein, Nicola P.4, Hanson, Kayla E.5, Markowitz, Lauri E.1, Wharton, Melinda1, McNally, Veronica V.6, Romero, José R.7, Talbot, H. Keipp8, Lee, Grace M.9, Daley, Matthew F.10
Source: MMWR: Morbidity & Mortality Weekly Report. 8/13/2021, Vol. 70 Issue 32, p1094-1099. 6p.
Database: Academic Search Ultimate
Description
ISSN:01492195
DOI:10.15585/mmwr.mm7032e4